The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Remicade Biosimilar Market Research Report 2024
Synopsis
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis.
The global Remicade Biosimilar market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for Remicade biosimilars is driven by the increasing demand for cost-effective biologic therapies and the expiration of Remicade's patent, leading to the entry of biosimilar competitors. The market's growth is also influenced by regulatory support for biosimilars and the ongoing development of new biologic therapies.
This report aims to provide a comprehensive presentation of the global market for Remicade Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remicade Biosimilar.
Report Scope
The Remicade Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Remicade Biosimilar market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Remicade Biosimilar manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Fosun Pharmaceutical
Livzon Pharmaceutical
Anke Biotechnology
Hualan Biological Engineering
Walvax Biotechnology
Hisun Pharmaceutical
Segment by Type
100mg/10ml
500mg/50ml
Segment by Application
Blood Disorders
Oncology Diseases
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Remicade Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Remicade Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis.
The global Remicade Biosimilar market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for Remicade biosimilars is driven by the increasing demand for cost-effective biologic therapies and the expiration of Remicade's patent, leading to the entry of biosimilar competitors. The market's growth is also influenced by regulatory support for biosimilars and the ongoing development of new biologic therapies.
This report aims to provide a comprehensive presentation of the global market for Remicade Biosimilar, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remicade Biosimilar.
Report Scope
The Remicade Biosimilar market size, estimations, and forecasts are provided in terms of sales volume (L) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Remicade Biosimilar market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Remicade Biosimilar manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)
Fosun Pharmaceutical
Livzon Pharmaceutical
Anke Biotechnology
Hualan Biological Engineering
Walvax Biotechnology
Hisun Pharmaceutical
Segment by Type
100mg/10ml
500mg/50ml
Segment by Application
Blood Disorders
Oncology Diseases
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Remicade Biosimilar manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Remicade Biosimilar in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Remicade Biosimilar Market Overview
1.1 Product Overview and Scope of Remicade Biosimilar
1.2 Remicade Biosimilar Segment by Type
1.2.1 Global Remicade Biosimilar Market Value Comparison by Type (2024-2030)
1.2.2 100mg/10ml
1.2.3 500mg/50ml
1.3 Remicade Biosimilar Segment by Application
1.3.1 Global Remicade Biosimilar Market Value by Application: (2024-2030)
1.3.2 Blood Disorders
1.3.3 Oncology Diseases
1.4 Global Remicade Biosimilar Market Size Estimates and Forecasts
1.4.1 Global Remicade Biosimilar Revenue 2019-2030
1.4.2 Global Remicade Biosimilar Sales 2019-2030
1.4.3 Global Remicade Biosimilar Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Remicade Biosimilar Market Competition by Manufacturers
2.1 Global Remicade Biosimilar Sales Market Share by Manufacturers (2019-2024)
2.2 Global Remicade Biosimilar Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Remicade Biosimilar Average Price by Manufacturers (2019-2024)
2.4 Global Remicade Biosimilar Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Remicade Biosimilar, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Remicade Biosimilar, Product Type & Application
2.7 Remicade Biosimilar Market Competitive Situation and Trends
2.7.1 Remicade Biosimilar Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Remicade Biosimilar Players Market Share by Revenue
2.7.3 Global Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Remicade Biosimilar Retrospective Market Scenario by Region
3.1 Global Remicade Biosimilar Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Remicade Biosimilar Global Remicade Biosimilar Sales by Region: 2019-2030
3.2.1 Global Remicade Biosimilar Sales by Region: 2019-2024
3.2.2 Global Remicade Biosimilar Sales by Region: 2025-2030
3.3 Global Remicade Biosimilar Global Remicade Biosimilar Revenue by Region: 2019-2030
3.3.1 Global Remicade Biosimilar Revenue by Region: 2019-2024
3.3.2 Global Remicade Biosimilar Revenue by Region: 2025-2030
3.4 North America Remicade Biosimilar Market Facts & Figures by Country
3.4.1 North America Remicade Biosimilar Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Remicade Biosimilar Sales by Country (2019-2030)
3.4.3 North America Remicade Biosimilar Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Remicade Biosimilar Market Facts & Figures by Country
3.5.1 Europe Remicade Biosimilar Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Remicade Biosimilar Sales by Country (2019-2030)
3.5.3 Europe Remicade Biosimilar Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Remicade Biosimilar Market Facts & Figures by Country
3.6.1 Asia Pacific Remicade Biosimilar Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Remicade Biosimilar Sales by Country (2019-2030)
3.6.3 Asia Pacific Remicade Biosimilar Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Remicade Biosimilar Market Facts & Figures by Country
3.7.1 Latin America Remicade Biosimilar Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Remicade Biosimilar Sales by Country (2019-2030)
3.7.3 Latin America Remicade Biosimilar Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Remicade Biosimilar Market Facts & Figures by Country
3.8.1 Middle East and Africa Remicade Biosimilar Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Remicade Biosimilar Sales by Country (2019-2030)
3.8.3 Middle East and Africa Remicade Biosimilar Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Remicade Biosimilar Sales by Type (2019-2030)
4.1.1 Global Remicade Biosimilar Sales by Type (2019-2024)
4.1.2 Global Remicade Biosimilar Sales by Type (2025-2030)
4.1.3 Global Remicade Biosimilar Sales Market Share by Type (2019-2030)
4.2 Global Remicade Biosimilar Revenue by Type (2019-2030)
4.2.1 Global Remicade Biosimilar Revenue by Type (2019-2024)
4.2.2 Global Remicade Biosimilar Revenue by Type (2025-2030)
4.2.3 Global Remicade Biosimilar Revenue Market Share by Type (2019-2030)
4.3 Global Remicade Biosimilar Price by Type (2019-2030)
5 Segment by Application
5.1 Global Remicade Biosimilar Sales by Application (2019-2030)
5.1.1 Global Remicade Biosimilar Sales by Application (2019-2024)
5.1.2 Global Remicade Biosimilar Sales by Application (2025-2030)
5.1.3 Global Remicade Biosimilar Sales Market Share by Application (2019-2030)
5.2 Global Remicade Biosimilar Revenue by Application (2019-2030)
5.2.1 Global Remicade Biosimilar Revenue by Application (2019-2024)
5.2.2 Global Remicade Biosimilar Revenue by Application (2025-2030)
5.2.3 Global Remicade Biosimilar Revenue Market Share by Application (2019-2030)
5.3 Global Remicade Biosimilar Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Synthon Pharmaceuticals
6.1.1 Synthon Pharmaceuticals Corporation Information
6.1.2 Synthon Pharmaceuticals Description and Business Overview
6.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Synthon Pharmaceuticals Remicade Biosimilar Product Portfolio
6.1.5 Synthon Pharmaceuticals Recent Developments/Updates
6.2 LG Life Sciences
6.2.1 LG Life Sciences Corporation Information
6.2.2 LG Life Sciences Description and Business Overview
6.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LG Life Sciences Remicade Biosimilar Product Portfolio
6.2.5 LG Life Sciences Recent Developments/Updates
6.3 Novartis (Sandoz)
6.3.1 Novartis (Sandoz) Corporation Information
6.3.2 Novartis (Sandoz) Description and Business Overview
6.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis (Sandoz) Remicade Biosimilar Product Portfolio
6.3.5 Novartis (Sandoz) Recent Developments/Updates
6.4 Celltrion
6.4.1 Celltrion Corporation Information
6.4.2 Celltrion Description and Business Overview
6.4.3 Celltrion Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Celltrion Remicade Biosimilar Product Portfolio
6.4.5 Celltrion Recent Developments/Updates
6.5 Biocon
6.5.1 Biocon Corporation Information
6.5.2 Biocon Description and Business Overview
6.5.3 Biocon Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biocon Remicade Biosimilar Product Portfolio
6.5.5 Biocon Recent Developments/Updates
6.6 Hospira
6.6.1 Hospira Corporation Information
6.6.2 Hospira Description and Business Overview
6.6.3 Hospira Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hospira Remicade Biosimilar Product Portfolio
6.6.5 Hospira Recent Developments/Updates
6.7 Merck Serono (Merck Group)
6.6.1 Merck Serono (Merck Group) Corporation Information
6.6.2 Merck Serono (Merck Group) Description and Business Overview
6.6.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck Serono (Merck Group) Remicade Biosimilar Product Portfolio
6.7.5 Merck Serono (Merck Group) Recent Developments/Updates
6.8 Biogen idec Inc.
6.8.1 Biogen idec Inc. Corporation Information
6.8.2 Biogen idec Inc. Description and Business Overview
6.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Biogen idec Inc. Remicade Biosimilar Product Portfolio
6.8.5 Biogen idec Inc. Recent Developments/Updates
6.9 Genentech (Roche Group)
6.9.1 Genentech (Roche Group) Corporation Information
6.9.2 Genentech (Roche Group) Description and Business Overview
6.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Genentech (Roche Group) Remicade Biosimilar Product Portfolio
6.9.5 Genentech (Roche Group) Recent Developments/Updates
6.10 Fosun Pharmaceutical
6.10.1 Fosun Pharmaceutical Corporation Information
6.10.2 Fosun Pharmaceutical Description and Business Overview
6.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Fosun Pharmaceutical Remicade Biosimilar Product Portfolio
6.10.5 Fosun Pharmaceutical Recent Developments/Updates
6.11 Livzon Pharmaceutical
6.11.1 Livzon Pharmaceutical Corporation Information
6.11.2 Livzon Pharmaceutical Remicade Biosimilar Description and Business Overview
6.11.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Livzon Pharmaceutical Remicade Biosimilar Product Portfolio
6.11.5 Livzon Pharmaceutical Recent Developments/Updates
6.12 Anke Biotechnology
6.12.1 Anke Biotechnology Corporation Information
6.12.2 Anke Biotechnology Remicade Biosimilar Description and Business Overview
6.12.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Anke Biotechnology Remicade Biosimilar Product Portfolio
6.12.5 Anke Biotechnology Recent Developments/Updates
6.13 Hualan Biological Engineering
6.13.1 Hualan Biological Engineering Corporation Information
6.13.2 Hualan Biological Engineering Remicade Biosimilar Description and Business Overview
6.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Hualan Biological Engineering Remicade Biosimilar Product Portfolio
6.13.5 Hualan Biological Engineering Recent Developments/Updates
6.14 Walvax Biotechnology
6.14.1 Walvax Biotechnology Corporation Information
6.14.2 Walvax Biotechnology Remicade Biosimilar Description and Business Overview
6.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Walvax Biotechnology Remicade Biosimilar Product Portfolio
6.14.5 Walvax Biotechnology Recent Developments/Updates
6.15 Hisun Pharmaceutical
6.15.1 Hisun Pharmaceutical Corporation Information
6.15.2 Hisun Pharmaceutical Remicade Biosimilar Description and Business Overview
6.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Hisun Pharmaceutical Remicade Biosimilar Product Portfolio
6.15.5 Hisun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Remicade Biosimilar Industry Chain Analysis
7.2 Remicade Biosimilar Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Remicade Biosimilar Production Mode & Process
7.4 Remicade Biosimilar Sales and Marketing
7.4.1 Remicade Biosimilar Sales Channels
7.4.2 Remicade Biosimilar Distributors
7.5 Remicade Biosimilar Customers
8 Remicade Biosimilar Market Dynamics
8.1 Remicade Biosimilar Industry Trends
8.2 Remicade Biosimilar Market Drivers
8.3 Remicade Biosimilar Market Challenges
8.4 Remicade Biosimilar Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
